Xtampza ER Alternatives Compared
| Xtampza ER | Oxycodone | Tramadol |
|
|---|
| Xtampza ER (oxycodone) | Oxycodone | Tramadol |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Chronic Pain, Pain. Xtampza ER may also be used for purposes not listed in this medication guide. |
Prescription only
Oxycodone is a semisynthetic opioid medication with potent pain-relieving properties that may be used to relieve severe pain that is unresponsive to less potent pain-relieving medicines (analgesics)... View more |
Prescription only
Tramadol is a strong opioid pain relieving medication that may be used to treat moderate to severe general and nerve-related pain. Tramadol may be habit-forming and misuse can cause addiction... View more |
Related suggestions |
|||||||||||||||||||||||
| More about Xtampza ER (oxycodone) | More about Oxycodone | More about Tramadol | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Xtampza ER has an average rating of 3.8 out of 10 from a total of 167 ratings on Drugs.com. 24% of reviewers reported a positive effect, while 63% reported a negative effect. |
Oxycodone has an average rating of 6.9 out of 10 from a total of 1134 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 25% reported a negative effect. |
Tramadol has an average rating of 7.0 out of 10 from a total of 1861 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Xtampza ER prices |
View all Oxycodone prices |
View all Tramadol prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other oxycodone brands include: Dazidox, Endocodone, ETH-Oxydose, Oxaydo, OxyContin, Oxydose, Oxyfast, Roxicodone, RoxyBond View more | Dazidox, Endocodone, ETH-Oxydose, Oxaydo, OxyContin, Oxydose, Oxyfast, Roxicodone, RoxyBond, Xtampza ER View more | ConZip, Qdolo, Tramadol Hydrochloride ER | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
5.6 hours |
5.6 hours |
5.2 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 594 drugs are known to interact with Xtampza ER:
|
A total of 594 drugs are known to interact with Oxycodone:
|
A total of 688 drugs are known to interact with Tramadol:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 26, 2016 |
October 26, 1998 |
March 03, 1995 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.